Literature DB >> 24844354

Wolman disease associated with hemophagocytic lymphohistiocytosis: attempts for an explanation.

Roberta Taurisano1, Arianna Maiorana, Fabrizio De Benedetti, Carlo Dionisi-Vici, Renata Boldrini, Federica Deodato.   

Abstract

UNLABELLED: The lysosomal acid lipase (LAL) is the enzyme responsible of the hydrolysis of cholesteryl esters and triglycerides within endo-lysosomes. Loss of enzyme activity leads to accumulation of cholesteryl esters and triglycerides in the lysosome of most tissues. The complete deficiency of LAL is responsible of Wolman disease (WD), a severe systemic disease manifesting in the first days of life with vomiting, diarrhea, failure to thrive, hepatosplenomegaly, jaundice, anemia, and thrombocytopenia. Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening condition which may be genetically determined or secondary to infections, malignancies, immune deficiencies, and rheumatologic disorders. So far, some inborn errors of metabolism have been associated with HLH (e.g., lysinuric protein intolerance, Gaucher's disease), and it has been anecdotally described in three WD patients, without any specific pathogenetic hypothesis. Here, we report on a WD patient, showing clear clinical, biochemical, and histological features indicative of HLH. We discuss the pathophysiological role of cholesteryl ester-induced inflammasome activation in macrophages, leading to a secondary HLH.
CONCLUSION: This case indicates that WD can cause secondary HLH and suggests that a careful metabolic workup should be performed when facing to a pediatric patient with HLH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24844354     DOI: 10.1007/s00431-014-2338-y

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

1.  Cobalamin C disease presenting with hemophagocytic lymphohistiocytosis.

Authors:  Susan Wu; Ignacio Gonzalez-Gomez; Thomas Coates; Shoji Yano
Journal:  Pediatr Hematol Oncol       Date:  2005-12       Impact factor: 1.969

2.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

3.  Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital, Montreal.

Authors:  Rebecca Perry; Oufae Kecha; Jean Paquette; Celine Huot; Guy Van Vliet; Cheri Deal
Journal:  J Clin Endocrinol Metab       Date:  2005-04-05       Impact factor: 5.958

4.  Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance.

Authors:  M Duval; O Fenneteau; V Doireau; A Faye; D Emilie; P Yotnda; J C Drapier; N Schlegel; G Sterkers; H O de Baulny; E Vilmer
Journal:  J Pediatr       Date:  1999-02       Impact factor: 4.406

5.  Secondary hemophagocytosis in 3 patients with organic acidemia involving propionate metabolism.

Authors:  M Gokce; O Unal; B Hismi; F Gumruk; T Coskun; G Balta; S Unal; M Cetin; H S Kalkanoglu-Sivri; A Dursun; A Tokatlı
Journal:  Pediatr Hematol Oncol       Date:  2011-10-04       Impact factor: 1.969

6.  Wolman disease and cholesteryl ester storage disease diagnosed by histological and ultrastructural examination of intestinal and liver biopsy.

Authors:  Renata Boldrini; Rita Devito; Roberto Biselli; Mirella Filocamo; Cesare Bosman
Journal:  Pathol Res Pract       Date:  2004       Impact factor: 3.250

7.  Wolman's disease: The King Faisal Specialist Hospital and Research Centre experience.

Authors:  M Al Essa; R Nounou; N Sakati; G Le Quesne; S Joshi; A Archibald; P T Ozand
Journal:  Ann Saudi Med       Date:  1998 Mar-Apr       Impact factor: 1.526

8.  Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation.

Authors:  Kristiina Rajamäki; Jani Lappalainen; Katariina Oörni; Elina Välimäki; Sampsa Matikainen; Petri T Kovanen; Kari K Eklund
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

9.  An unusual presentation of galactosemia: hemophagocytic lymphohistiocytosis.

Authors:  Ahmet Afşin Kundak; Ayşegül Zenciroğlu; Neşe Yaralı; Belma Saygılı Karagöl; Arzu Dursun; Selim Gökçe; Nilgün Karadağ; Nurullah Okumuş
Journal:  Turk J Haematol       Date:  2012-12-05       Impact factor: 1.831

Review 10.  The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome.

Authors:  Cristina Rosário; Gisele Zandman-Goddard; Esther G Meyron-Holtz; David P D'Cruz; Yehuda Shoenfeld
Journal:  BMC Med       Date:  2013-08-22       Impact factor: 8.775

  10 in total
  18 in total

Review 1.  Pediatric hemophagocytic lymphohistiocytosis.

Authors:  Scott W Canna; Rebecca A Marsh
Journal:  Blood       Date:  2020-04-16       Impact factor: 22.113

Review 2.  Lysosomal Acid Lipase Deficiency: Therapeutic Options.

Authors:  Gregory M Pastores; Derralynn A Hughes
Journal:  Drug Des Devel Ther       Date:  2020-02-11       Impact factor: 4.162

3.  Secondary Hemophagocytic Syndrome Associated with COG6 Gene Defect: Report and Review.

Authors:  Nouf Althonaian; Abdulrahman Alsultan; Eva Morava; Majid Alfadhel
Journal:  JIMD Rep       Date:  2018-02-15

4.  Effective Immunological Guidance of Genetic Analyses Including Exome Sequencing in Patients Evaluated for Hemophagocytic Lymphohistiocytosis.

Authors:  Sandra Ammann; Kai Lehmberg; Udo Zur Stadt; Christian Klemann; Sebastian F N Bode; Carsten Speckmann; Gritta Janka; Katharina Wustrau; Mirzokhid Rakhmanov; Ilka Fuchs; Hans C Hennies; Stephan Ehl
Journal:  J Clin Immunol       Date:  2017-09-21       Impact factor: 8.317

5.  Frequency and spectrum of disease-causing variants in 1892 patients with suspected genetic HLH disorders.

Authors:  Vanessa Gadoury-Levesque; Lei Dong; Rui Su; Jianjun Chen; Kejian Zhang; Kimberly A Risma; Rebecca A Marsh; Miao Sun
Journal:  Blood Adv       Date:  2020-06-23

6.  Enzyme replacement therapy and hematopoietic stem cell transplant: a new paradigm of treatment in Wolman disease.

Authors:  Jane E Potter; Gemma Petts; Arunabha Ghosh; Fiona J White; Jane L Kinsella; Stephen Hughes; Jane Roberts; Adam Hodgkinson; Kathryn Brammeier; Heather Church; Christine Merrigan; Joanne Hughes; Pamela Evans; Helen Campbell; Denise Bonney; William G Newman; Brian W Bigger; Alexander Broomfield; Simon A Jones; Robert F Wynn
Journal:  Orphanet J Rare Dis       Date:  2021-05-21       Impact factor: 4.123

7.  Secondary Hemophagocytic Lymphohistiocytosis in an Infant with Wolman Disease.

Authors:  Sandip Bartakke; Amit Nisal; Vibha Bafna; Aashna Valecha
Journal:  Indian J Hematol Blood Transfus       Date:  2020-09-11       Impact factor: 0.900

8.  Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.

Authors:  Simon A Jones; Sandra Rojas-Caro; Anthony G Quinn; Mark Friedman; Sachin Marulkar; Fatih Ezgu; Osama Zaki; J Jay Gargus; Joanne Hughes; Dominique Plantaz; Roshni Vara; Stephen Eckert; Jean-Baptiste Arnoux; Anais Brassier; Kim-Hanh Le Quan Sang; Vassili Valayannopoulos
Journal:  Orphanet J Rare Dis       Date:  2017-02-08       Impact factor: 4.123

9.  A nine-month-old-boy with Atypical Hemophagocytic Lymphohistiocytosis.

Authors:  Monia Ouederni; Monia Ben Khaled; Samia Rekaya; Ilhem Ben Fraj; Fethi Mellouli; Mohamed Bejaoui
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-10-16       Impact factor: 2.576

10.  Secondary Hemophagocytic Lymphohistiocytosis in an Infant with Wolman Disease.

Authors:  Aynur Küçükçongar Yavaş; Betül Orhaner; Pınar Genç; Nevin Kılıç; Hakan Erdoğan; Özlem Özdemir; Arzu Ekici
Journal:  Turk J Haematol       Date:  2016-04-18       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.